MedPath

Pivotal Study of the LVIS (Low Profile Visualized Intraluminal Support)

Not Applicable
Completed
Conditions
Intracranial Aneurysms
Interventions
Device: LVIS™ and LVIS™ Jr
Registration Number
NCT01793792
Lead Sponsor
Microvention-Terumo, Inc.
Brief Summary

The purpose of this study is to evaluate the safety and efficacy of the Low Profile Visualized Intraluminal Support(LVIS™ and LVIS™ Jr.)devices from MicroVention, Inc. when used to facilitate endovascular coiling of wide-necked intracranial aneurysms with coils.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
153
Inclusion Criteria
  • Subject age between 18 and 75 years
  • Subject with an unruptured or ruptured(>30days since occurence), wide-necked (neck ≥4mm or dome to neck ratio <2)intracranial saccular aneurysm (<20mm maximum diameter in any plane)
Exclusion Criteria
  • Subject with significant extra or intracranial stenosis of the parent artery (>50%) proximal to the target aneurysm.
  • Subject with any condition which in the opinion of the treating physician would place the subject at high risk of embolic stroke
  • Subject with contraindications to the use of antiplatelet agents
  • Subject who is unable to complete the required follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Device: LVISLVIS™ and LVIS™ JrThe LVIS Device is intended for use with embolization coils for the treatment of wide neck, intracranial aneurysms. Device: LVIS™ and LVIS™ Jr. MicroVention Low-profile Visualized Intraluminal Support Device
Primary Outcome Measures
NameTimeMethod
Primary Effectiveness Composite Success "Number of Participants With Primary Effectiveness Composite Success (100% Aneurysm Occlusion Without Clinically Significant In-stent Stenosis or Target Aneurysm Retreatment"12 months
Primary Safety Composite Rate (Disabling Stroke With mRS Score Greater Than or Equal to 3, or Neurological Death Within 12 Months12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (21)

Colorado Neurological Institute

🇺🇸

Englewood, Colorado, United States

Albany Medical College

🇺🇸

Albany, New York, United States

Indiana University/Methodist Research Institute

🇺🇸

Indianapolis, Indiana, United States

Tufts Medical Center

🇺🇸

Boston, Massachusetts, United States

Abbott Northwestern Hospital

🇺🇸

Minneapolis, Minnesota, United States

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

The Methodist Hospital

🇺🇸

Houston, Texas, United States

Advocate Health and Hospital

🇺🇸

Oak Lawn, Illinois, United States

Stony Brook University Medical Center

🇺🇸

Stony Brook, New York, United States

St. Luke's Roosevelt Hospital Center

🇺🇸

New York, New York, United States

Cleveland Clinic Foundation

🇺🇸

Cleveland, Ohio, United States

Dignity Health/Mercy San Juan Medical Center

🇺🇸

Carmichael, California, United States

Rush University Medical Center

🇺🇸

Chicago, Illinois, United States

University of Maryland

🇺🇸

Baltimore, Maryland, United States

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

North Shore University Hospital

🇺🇸

Manhasset, New York, United States

University of Pittsburgh Medical Center

🇺🇸

Pittsburgh, Pennsylvania, United States

Methodist University Hospital

🇺🇸

Memphis, Tennessee, United States

Vanderbilt University

🇺🇸

Nashville, Tennessee, United States

University at Buffalo Neurosurgery

🇺🇸

Buffalo, New York, United States

St. Joseph's Hospital and Medical Center

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath